Prescott Group Funds Buy 291,666 NATR Shares for $2.85M in Open Market
NATR sits 17% above its 52-week low of $9.376.
Summary
Prescott Group's funds bought 291,666 NATR shares for $2.85 million at $9.50-$9.95 on 2026-11-05, raising their stake to 2,236,152 shares — a much larger buy than their August purchase and made just after weak Q3 results and a guidance cut.
Key Events · Ownership and Investor Activity · NATR
-
Prescott Funds Add 291,666 Shares
Five Prescott Group reporting entities bought 291,666 shares for $2,849,810.84 across 20 open-market trades on 2026-11-05, at prices from $9.50 to $9.95.
-
Stake Rises to 2,236,152 Shares
Post-transaction indirect holdings reached 2,236,152 shares, held through the Master Fund for the accounts of the two Small Cap funds.
-
Buy Follows Weak Q3 and Guidance Cut
The purchase came one day after the 2026-11-04 8-K reporting Q3 sales down 9% to $116.6 million, EPS of $0.11 versus $0.30, and a cut to full-year sales guidance.
-
Far Larger Than August Purchase
The 2026-08-19 Form 4 reported 20,000 shares bought for $293,800; this buy is about ten times that dollar amount and roughly 1.5% of market cap.
Analysis · NATR · Life Sciences
Phil Frohlich's Prescott Group funds bought 291,666 shares for $2,849,810.84 at $9.50-$9.95 on 2026-11-05, lifting their combined stake to 2,236,152 shares. This is a genuine open-market purchase, not an option exercise or grant, and it is roughly ten times the size of the 20,000-share buy the same group reported on 2026-08-19. The buying came in the days right after Q3 results showed sales down 9% to $116.6 million and management cut full-year sales guidance, so the fund was adding while the stock was under pressure. One caveat: this is a financial 10% owner, not an operator, so the read-through is conviction in valuation rather than a view on day-to-day execution.
How filings like this one have moved
In the 30 days to Nov 9, 2026, 47.1% of the 1533 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, NATR was trading at $10.95 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $191M. The 52-week trading range was $9.38 to $28.14. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.